

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular visceral epithelial cell development (GO:0072015) | 6.73113810 |
| 2 | glomerular epithelial cell development (GO:0072310) | 6.04469262 |
| 3 | glomerular basement membrane development (GO:0032836) | 5.54913354 |
| 4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.22170672 |
| 5 | hemidesmosome assembly (GO:0031581) | 4.82326960 |
| 6 | intestinal absorption (GO:0050892) | 4.32875920 |
| 7 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.20951164 |
| 8 | lysine metabolic process (GO:0006553) | 4.20744097 |
| 9 | lysine catabolic process (GO:0006554) | 4.20744097 |
| 10 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.03441442 |
| 11 | epithelial cell-cell adhesion (GO:0090136) | 4.00835158 |
| 12 | desmosome organization (GO:0002934) | 3.90049907 |
| 13 | renal filtration (GO:0097205) | 3.89563489 |
| 14 | regulation of hippo signaling (GO:0035330) | 3.88663190 |
| 15 | lymphangiogenesis (GO:0001946) | 3.86667875 |
| 16 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.63343627 |
| 17 | surfactant homeostasis (GO:0043129) | 3.60868728 |
| 18 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59905527 |
| 19 | regulation of bile acid biosynthetic process (GO:0070857) | 3.58085816 |
| 20 | lymph vessel development (GO:0001945) | 3.57868785 |
| 21 | blood vessel endothelial cell migration (GO:0043534) | 3.51701469 |
| 22 | proline biosynthetic process (GO:0006561) | 3.48907851 |
| 23 | intestinal cholesterol absorption (GO:0030299) | 3.47527496 |
| 24 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.45977943 |
| 25 | endothelium development (GO:0003158) | 3.40944218 |
| 26 | protein retention in ER lumen (GO:0006621) | 3.39384376 |
| 27 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.38197805 |
| 28 | cell-substrate junction assembly (GO:0007044) | 3.38187110 |
| 29 | angiotensin maturation (GO:0002003) | 3.36799917 |
| 30 | proline metabolic process (GO:0006560) | 3.35281167 |
| 31 | cysteine metabolic process (GO:0006534) | 3.32416500 |
| 32 | protein carboxylation (GO:0018214) | 3.31500190 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.31500190 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.30565650 |
| 35 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.27829026 |
| 36 | positive regulation of p38MAPK cascade (GO:1900745) | 3.27152050 |
| 37 | transcytosis (GO:0045056) | 3.24152012 |
| 38 | regulation of cholesterol homeostasis (GO:2000188) | 3.22733383 |
| 39 | plasma lipoprotein particle assembly (GO:0034377) | 3.21054804 |
| 40 | carnitine shuttle (GO:0006853) | 3.18362960 |
| 41 | regulation of p38MAPK cascade (GO:1900744) | 3.18067836 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.16484129 |
| 43 | L-phenylalanine metabolic process (GO:0006558) | 3.16484129 |
| 44 | fatty acid transmembrane transport (GO:1902001) | 3.14700104 |
| 45 | basement membrane organization (GO:0071711) | 3.13343338 |
| 46 | aspartate family amino acid catabolic process (GO:0009068) | 3.09195790 |
| 47 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.07613523 |
| 48 | response to mercury ion (GO:0046689) | 3.06016683 |
| 49 | drug transmembrane transport (GO:0006855) | 3.04358444 |
| 50 | fatty acid beta-oxidation (GO:0006635) | 3.03296448 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 3.01996421 |
| 52 | carnitine transport (GO:0015879) | 3.00290003 |
| 53 | amino-acid betaine transport (GO:0015838) | 3.00290003 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 3.00235595 |
| 55 | urea cycle (GO:0000050) | 2.99717198 |
| 56 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.97900838 |
| 57 | endothelial cell chemotaxis (GO:0035767) | 2.97424969 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.97001094 |
| 59 | L-phenylalanine catabolic process (GO:0006559) | 2.97001094 |
| 60 | NADH metabolic process (GO:0006734) | 2.94203218 |
| 61 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.94112294 |
| 62 | endothelial cell morphogenesis (GO:0001886) | 2.93297652 |
| 63 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.93242510 |
| 64 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.92569372 |
| 65 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.92569372 |
| 66 | endocrine process (GO:0050886) | 2.92569372 |
| 67 | glomerulus development (GO:0032835) | 2.91481124 |
| 68 | protein-lipid complex assembly (GO:0065005) | 2.91472964 |
| 69 | sulfur amino acid catabolic process (GO:0000098) | 2.89203446 |
| 70 | renal absorption (GO:0070293) | 2.88921205 |
| 71 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.88660782 |
| 72 | GDP-mannose metabolic process (GO:0019673) | 2.88375549 |
| 73 | quaternary ammonium group transport (GO:0015697) | 2.87993425 |
| 74 | regulation of guanylate cyclase activity (GO:0031282) | 2.86146701 |
| 75 | venous blood vessel morphogenesis (GO:0048845) | 2.85715695 |
| 76 | sarcomere organization (GO:0045214) | 2.85680664 |
| 77 | lung vasculature development (GO:0060426) | 2.85276981 |
| 78 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.84509001 |
| 79 | Golgi transport vesicle coating (GO:0048200) | 2.84123756 |
| 80 | COPI coating of Golgi vesicle (GO:0048205) | 2.84123756 |
| 81 | plasma membrane repair (GO:0001778) | 2.83818813 |
| 82 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.83215262 |
| 83 | homocysteine metabolic process (GO:0050667) | 2.83040858 |
| 84 | urea metabolic process (GO:0019627) | 2.82798712 |
| 85 | carnitine metabolic process (GO:0009437) | 2.82299238 |
| 86 | fatty acid oxidation (GO:0019395) | 2.81848349 |
| 87 | lipoprotein metabolic process (GO:0042157) | 2.81834312 |
| 88 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.81520013 |
| 89 | negative regulation of fatty acid transport (GO:2000192) | 2.80963479 |
| 90 | adherens junction assembly (GO:0034333) | 2.80073999 |
| 91 | diacylglycerol metabolic process (GO:0046339) | 2.79446956 |
| 92 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.78803075 |
| 93 | urate metabolic process (GO:0046415) | 2.78444397 |
| 94 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.78266661 |
| 95 | drug catabolic process (GO:0042737) | 2.75531093 |
| 96 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.75210556 |
| 97 | phosphate ion transport (GO:0006817) | 2.75000122 |
| 98 | actin filament depolymerization (GO:0030042) | 2.74858459 |
| 99 | lipid oxidation (GO:0034440) | 2.74053295 |
| 100 | activation of Rac GTPase activity (GO:0032863) | 2.73687766 |
| 101 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.73386216 |
| 102 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.72539444 |
| 103 | cell adhesion mediated by integrin (GO:0033627) | 2.72508391 |
| 104 | carnitine transmembrane transport (GO:1902603) | 2.72401463 |
| 105 | positive regulation of pseudopodium assembly (GO:0031274) | 2.72260475 |
| 106 | high-density lipoprotein particle remodeling (GO:0034375) | 2.71647286 |
| 107 | tricarboxylic acid metabolic process (GO:0072350) | 2.70636862 |
| 108 | regulation of systemic arterial blood pressure (GO:0003073) | 2.69301382 |
| 109 | valine metabolic process (GO:0006573) | 2.69250707 |
| 110 | metanephric epithelium development (GO:0072207) | 2.69075123 |
| 111 | chemical homeostasis within a tissue (GO:0048875) | 2.68911140 |
| 112 | regulation of cholesterol esterification (GO:0010872) | 2.68121996 |
| 113 | coronary vasculature morphogenesis (GO:0060977) | 2.66676366 |
| 114 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.66640244 |
| 115 | regulation of plasminogen activation (GO:0010755) | 2.66227335 |
| 116 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.65475538 |
| 117 | regulation of fibrinolysis (GO:0051917) | 2.65233353 |
| 118 | protein-lipid complex remodeling (GO:0034368) | 2.65055991 |
| 119 | macromolecular complex remodeling (GO:0034367) | 2.65055991 |
| 120 | plasma lipoprotein particle remodeling (GO:0034369) | 2.65055991 |
| 121 | gap junction assembly (GO:0016264) | 2.64899621 |
| 122 | phosphate ion transmembrane transport (GO:0035435) | 2.64865045 |
| 123 | renal system process involved in regulation of blood volume (GO:0001977) | 2.64686199 |
| 124 | cell-cell junction maintenance (GO:0045217) | 2.64662298 |
| 125 | glomerular filtration (GO:0003094) | 2.64303406 |
| 126 | regulation of metalloenzyme activity (GO:0048552) | 2.63498102 |
| 127 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.61702443 |
| 128 | 4-hydroxyproline metabolic process (GO:0019471) | 2.60974449 |
| 129 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.60588897 |
| 130 | response to hepatocyte growth factor (GO:0035728) | 2.60588897 |
| 131 | ethanol oxidation (GO:0006069) | 2.60231313 |
| 132 | regulation of glomerular filtration (GO:0003093) | 2.59345292 |
| 133 | cellular ketone body metabolic process (GO:0046950) | 2.59155286 |
| 134 | regulation of cardioblast differentiation (GO:0051890) | 2.59022622 |
| 135 | focal adhesion assembly (GO:0048041) | 2.58369069 |
| 136 | cell-substrate adherens junction assembly (GO:0007045) | 2.58369069 |
| 137 | wound healing, spreading of epidermal cells (GO:0035313) | 2.58250690 |
| 138 | metanephric nephron epithelium development (GO:0072243) | 2.57539685 |
| 139 | acetyl-CoA metabolic process (GO:0006084) | 2.57288089 |
| 140 | hippo signaling (GO:0035329) | 2.57106153 |
| 141 | serine family amino acid catabolic process (GO:0009071) | 2.56187972 |
| 142 | plasma lipoprotein particle organization (GO:0071827) | 2.55921739 |
| 143 | short-chain fatty acid metabolic process (GO:0046459) | 2.55297997 |
| 144 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.54901746 |
| 145 | atrioventricular valve morphogenesis (GO:0003181) | 2.53548021 |
| 146 | fatty acid catabolic process (GO:0009062) | 2.53233776 |
| 147 | protein localization to endosome (GO:0036010) | 2.52755672 |
| 148 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.51925650 |
| 149 | lung epithelium development (GO:0060428) | 2.51273890 |
| 150 | patterning of blood vessels (GO:0001569) | 2.50620635 |
| 151 | regulation of extracellular matrix disassembly (GO:0010715) | 2.50484638 |
| 152 | regulation of endothelial cell differentiation (GO:0045601) | 2.50438874 |
| 153 | negative regulation of fibrinolysis (GO:0051918) | 2.49537867 |
| 154 | peptide catabolic process (GO:0043171) | 2.49356388 |
| 155 | exogenous drug catabolic process (GO:0042738) | 2.48750300 |
| 156 | regulation of tight junction assembly (GO:2000810) | 2.48660083 |
| 157 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.48553654 |
| 158 | peptidyl-proline hydroxylation (GO:0019511) | 2.47976112 |
| 159 | establishment of apical/basal cell polarity (GO:0035089) | 2.47623517 |
| 160 | regulation of cholesterol metabolic process (GO:0090181) | 2.47096954 |
| 161 | regulation of pseudopodium assembly (GO:0031272) | 2.46068897 |
| 162 | low-density lipoprotein particle remodeling (GO:0034374) | 2.44938836 |
| 163 | keratinocyte proliferation (GO:0043616) | 2.44689585 |
| 164 | chondrocyte proliferation (GO:0035988) | 2.44180557 |
| 165 | protein-lipid complex subunit organization (GO:0071825) | 2.43733648 |
| 166 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.43174068 |
| 167 | sexual reproduction (GO:0019953) | 2.41879747 |
| 168 | cholesterol homeostasis (GO:0042632) | 2.40554619 |
| 169 | regulation of water loss via skin (GO:0033561) | 2.40159824 |
| 170 | cellular zinc ion homeostasis (GO:0006882) | 2.39103267 |
| 171 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.38945435 |
| 172 | reverse cholesterol transport (GO:0043691) | 2.38102562 |
| 173 | apoptotic process involved in morphogenesis (GO:0060561) | 2.37229261 |
| 174 | positive regulation of osteoblast proliferation (GO:0033690) | 2.37130644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.51975684 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.88511319 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83449841 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.45426676 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.29420244 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.14489691 |
| 7 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.12344117 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.03960279 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84928952 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.73394560 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.70232007 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.57854399 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.50029527 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.30206791 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.25393888 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23753640 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.18841680 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17719069 |
| 19 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.80789765 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.80682542 |
| 21 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.79681237 |
| 22 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74235707 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.72175667 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71375559 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.70772211 |
| 26 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.69584443 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.68549918 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.68165558 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61446963 |
| 30 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.59973464 |
| 31 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.59715600 |
| 32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.59715600 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59663334 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.58174168 |
| 35 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.56637004 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56330065 |
| 37 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.56095027 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55358744 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55166964 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.54076958 |
| 41 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.53493829 |
| 42 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49962221 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49383149 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47529316 |
| 45 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.47317651 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46646987 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.43758174 |
| 48 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.38906732 |
| 49 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.38882069 |
| 50 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.38622315 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.37828132 |
| 52 | P68_20966046_ChIP-Seq_HELA_Human | 1.36933999 |
| 53 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.35730252 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35678359 |
| 55 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.33148028 |
| 56 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.32041559 |
| 57 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31746624 |
| 58 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.31359786 |
| 59 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29191906 |
| 60 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29191906 |
| 61 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.28227023 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26188508 |
| 63 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.25579191 |
| 64 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24736792 |
| 65 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.23726662 |
| 66 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.23432421 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22469759 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20423737 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20145693 |
| 70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18895371 |
| 71 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18390151 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.17985543 |
| 73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16330530 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16319602 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15824542 |
| 76 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.15135274 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14894727 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14857696 |
| 79 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14533537 |
| 80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14475485 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14460154 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13607741 |
| 83 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13229297 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11886831 |
| 85 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10647683 |
| 86 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08974132 |
| 87 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.07953799 |
| 88 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.07953799 |
| 89 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.07953799 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07480333 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06345284 |
| 92 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06222812 |
| 93 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05938424 |
| 94 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05620683 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04752575 |
| 96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04682186 |
| 97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04507641 |
| 98 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04472870 |
| 99 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.04430173 |
| 100 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04392703 |
| 101 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04098419 |
| 102 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03324471 |
| 103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03167411 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02992593 |
| 105 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02646742 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01990576 |
| 107 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01846678 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01672630 |
| 109 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01027250 |
| 110 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99938329 |
| 111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99795936 |
| 112 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98579067 |
| 113 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97749605 |
| 114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97282262 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96575576 |
| 116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95879610 |
| 117 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95670632 |
| 118 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95658060 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94887083 |
| 120 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94570312 |
| 121 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94467104 |
| 122 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94328008 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94250087 |
| 124 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94243753 |
| 125 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93761898 |
| 126 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90553714 |
| 127 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.90191222 |
| 128 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.89958646 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89665893 |
| 130 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89647416 |
| 131 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88999694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.53199778 |
| 2 | MP0010368_abnormal_lymphatic_system | 3.51725420 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.42587530 |
| 4 | MP0004272_abnormal_basement_membrane | 3.21554405 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 2.89314637 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 2.79220092 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.78533232 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.75897403 |
| 9 | MP0000566_synostosis | 2.69624206 |
| 10 | MP0001879_abnormal_lymphatic_vessel | 2.67062333 |
| 11 | MP0000678_abnormal_parathyroid_gland | 2.63767615 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.62131205 |
| 13 | MP0005409_darkened_coat_color | 2.61105762 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.49804263 |
| 15 | MP0003252_abnormal_bile_duct | 2.43772636 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.25178366 |
| 17 | MP0005365_abnormal_bile_salt | 2.22089142 |
| 18 | MP0002796_impaired_skin_barrier | 2.11012629 |
| 19 | MP0000537_abnormal_urethra_morphology | 2.10576546 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.99195537 |
| 21 | MP0005332_abnormal_amino_acid | 1.95830650 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.95694085 |
| 23 | MP0000762_abnormal_tongue_morphology | 1.92158412 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.78573778 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77710296 |
| 26 | MP0004036_abnormal_muscle_relaxation | 1.67867069 |
| 27 | MP0005670_abnormal_white_adipose | 1.67551390 |
| 28 | MP0006138_congestive_heart_failure | 1.64086672 |
| 29 | MP0002089_abnormal_postnatal_growth/wei | 1.61770383 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.61204795 |
| 31 | MP0005410_abnormal_fertilization | 1.59563106 |
| 32 | MP0005275_abnormal_skin_tensile | 1.56593642 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.55915145 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.54907390 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.54199330 |
| 36 | MP0004858_abnormal_nervous_system | 1.52130318 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.51980628 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.50379603 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.47737147 |
| 40 | MP0005083_abnormal_biliary_tract | 1.41415256 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.41181707 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.40796166 |
| 43 | MP0002254_reproductive_system_inflammat | 1.40679868 |
| 44 | MP0005501_abnormal_skin_physiology | 1.37521548 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.37014304 |
| 46 | MP0003941_abnormal_skin_development | 1.35466700 |
| 47 | MP0010630_abnormal_cardiac_muscle | 1.34452165 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.33921570 |
| 49 | MP0000751_myopathy | 1.30825052 |
| 50 | MP0005330_cardiomyopathy | 1.29515708 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.29026895 |
| 52 | MP0002136_abnormal_kidney_physiology | 1.28229783 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.27142648 |
| 54 | MP0008775_abnormal_heart_ventricle | 1.25586052 |
| 55 | MP0001544_abnormal_cardiovascular_syste | 1.25202101 |
| 56 | MP0005385_cardiovascular_system_phenoty | 1.25202101 |
| 57 | MP0003828_pulmonary_edema | 1.25008330 |
| 58 | MP0001348_abnormal_lacrimal_gland | 1.24399532 |
| 59 | MP0004130_abnormal_muscle_cell | 1.22400648 |
| 60 | MP0002972_abnormal_cardiac_muscle | 1.21052639 |
| 61 | MP0003315_abnormal_perineum_morphology | 1.20835381 |
| 62 | MP0005375_adipose_tissue_phenotype | 1.20791869 |
| 63 | MP0004087_abnormal_muscle_fiber | 1.19340652 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.17204336 |
| 65 | MP0001756_abnormal_urination | 1.16688016 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.16337877 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 1.16282543 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.14417768 |
| 69 | MP0001849_ear_inflammation | 1.12644804 |
| 70 | MP0005023_abnormal_wound_healing | 1.12514718 |
| 71 | MP0010030_abnormal_orbit_morphology | 1.10621581 |
| 72 | MP0001958_emphysema | 1.10246099 |
| 73 | MP0005165_increased_susceptibility_to | 1.10087513 |
| 74 | MP0003868_abnormal_feces_composition | 1.07079679 |
| 75 | MP0002060_abnormal_skin_morphology | 1.05998366 |
| 76 | MP0002249_abnormal_larynx_morphology | 1.04015111 |
| 77 | MP0000750_abnormal_muscle_regeneration | 1.02612324 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 1.02471912 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.02095144 |
| 80 | MP0008004_abnormal_stomach_pH | 1.01431450 |
| 81 | MP0002896_abnormal_bone_mineralization | 1.00807610 |
| 82 | MP0006054_spinal_hemorrhage | 1.00785797 |
| 83 | MP0003091_abnormal_cell_migration | 1.00744705 |
| 84 | MP0005620_abnormal_muscle_contractility | 0.99340761 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.98510571 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.98392574 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.97671381 |
| 88 | MP0002128_abnormal_blood_circulation | 0.97261435 |
| 89 | MP0010678_abnormal_skin_adnexa | 0.97156348 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 0.94850379 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.93889373 |
| 92 | MP0000609_abnormal_liver_physiology | 0.91884722 |
| 93 | MP0009840_abnormal_foam_cell | 0.91296210 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.91248771 |
| 95 | MP0001216_abnormal_epidermal_layer | 0.91140499 |
| 96 | MP0004484_altered_response_of | 0.91057023 |
| 97 | MP0002928_abnormal_bile_duct | 0.90935593 |
| 98 | MP0003279_aneurysm | 0.90852666 |
| 99 | MP0004133_heterotaxia | 0.90341051 |
| 100 | MP0010771_integument_phenotype | 0.89022787 |
| 101 | MP0000538_abnormal_urinary_bladder | 0.89003137 |
| 102 | MP0009053_abnormal_anal_canal | 0.88211621 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.88185475 |
| 104 | MP0002925_abnormal_cardiovascular_devel | 0.87399875 |
| 105 | MP0002269_muscular_atrophy | 0.86661809 |
| 106 | MP0000467_abnormal_esophagus_morphology | 0.86658849 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.85481786 |
| 108 | MP0000477_abnormal_intestine_morphology | 0.84776216 |
| 109 | MP0004043_abnormal_pH_regulation | 0.83985833 |
| 110 | MP0000749_muscle_degeneration | 0.83256602 |
| 111 | MP0000462_abnormal_digestive_system | 0.83233296 |
| 112 | MP0001614_abnormal_blood_vessel | 0.82656971 |
| 113 | MP0002135_abnormal_kidney_morphology | 0.81339682 |
| 114 | MP0008260_abnormal_autophagy | 0.80915197 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.80123308 |
| 116 | MP0003283_abnormal_digestive_organ | 0.79959515 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.79470250 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.79048513 |
| 119 | MP0000747_muscle_weakness | 0.78998649 |
| 120 | MP0003718_maternal_effect | 0.78985439 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.77571997 |
| 122 | MP0000266_abnormal_heart_morphology | 0.77545650 |
| 123 | MP0000579_abnormal_nail_morphology | 0.76360600 |
| 124 | MP0000534_abnormal_ureter_morphology | 0.75810676 |
| 125 | MP0003115_abnormal_respiratory_system | 0.75200024 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.75185232 |
| 127 | MP0005451_abnormal_body_composition | 0.74491406 |
| 128 | MP0001664_abnormal_digestion | 0.68768034 |
| 129 | MP0009379_abnormal_foot_pigmentation | 0.68530300 |
| 130 | MP0003755_abnormal_palate_morphology | 0.68332053 |
| 131 | MP0002086_abnormal_extraembryonic_tissu | 0.68094272 |
| 132 | MP0000733_abnormal_muscle_development | 0.67112219 |
| 133 | MP0002697_abnormal_eye_size | 0.65336397 |
| 134 | MP0001730_embryonic_growth_arrest | 0.64785440 |
| 135 | MP0009931_abnormal_skin_appearance | 0.64005396 |
| 136 | MP0001661_extended_life_span | 0.63981247 |
| 137 | MP0000377_abnormal_hair_follicle | 0.62273095 |
| 138 | MP0004233_abnormal_muscle_weight | 0.62239888 |
| 139 | MP0003119_abnormal_digestive_system | 0.59664896 |
| 140 | MP0003879_abnormal_hair_cell | 0.58062167 |
| 141 | MP0003385_abnormal_body_wall | 0.56350320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 5.26454084 |
| 2 | Focal segmental glomerulosclerosis (HP:0000097) | 4.49678127 |
| 3 | Mesangial abnormality (HP:0001966) | 4.35742277 |
| 4 | Gout (HP:0001997) | 3.91402507 |
| 5 | Glomerulosclerosis (HP:0000096) | 3.90260383 |
| 6 | Ventricular tachycardia (HP:0004756) | 3.78200543 |
| 7 | Esophageal varix (HP:0002040) | 3.68529757 |
| 8 | Deep venous thrombosis (HP:0002625) | 3.66994561 |
| 9 | Lymphangioma (HP:0100764) | 3.64240174 |
| 10 | Muscle fiber splitting (HP:0003555) | 3.46864718 |
| 11 | Increased connective tissue (HP:0009025) | 3.38352942 |
| 12 | Hyperglycinuria (HP:0003108) | 3.19593731 |
| 13 | Alopecia of scalp (HP:0002293) | 3.13086955 |
| 14 | Flat acetabular roof (HP:0003180) | 3.10872070 |
| 15 | Pterygium (HP:0001059) | 3.06461873 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.04296790 |
| 17 | Hyperactive renin-angiotensin system (HP:0000841) | 3.03439208 |
| 18 | Sudden death (HP:0001699) | 3.03104363 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 2.99112115 |
| 20 | Milia (HP:0001056) | 2.93398258 |
| 21 | Premature rupture of membranes (HP:0001788) | 2.91011754 |
| 22 | Protrusio acetabuli (HP:0003179) | 2.88874431 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.88092349 |
| 24 | Polycythemia (HP:0001901) | 2.84735774 |
| 25 | Fragile skin (HP:0001030) | 2.79606412 |
| 26 | Broad face (HP:0000283) | 2.76627364 |
| 27 | Xanthomatosis (HP:0000991) | 2.74667479 |
| 28 | Intrahepatic cholestasis (HP:0001406) | 2.69007219 |
| 29 | Hyperammonemia (HP:0001987) | 2.68827296 |
| 30 | Hypokalemic alkalosis (HP:0001949) | 2.67690715 |
| 31 | Hypobetalipoproteinemia (HP:0003563) | 2.67525714 |
| 32 | Onycholysis (HP:0001806) | 2.65612767 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.64100237 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 2.64100237 |
| 35 | Ketoacidosis (HP:0001993) | 2.63665937 |
| 36 | Increased purine levels (HP:0004368) | 2.63471538 |
| 37 | Hyperuricemia (HP:0002149) | 2.63471538 |
| 38 | Abnormality of carpal bone ossification (HP:0006257) | 2.63038074 |
| 39 | Thick nail (HP:0001805) | 2.61011424 |
| 40 | Ketosis (HP:0001946) | 2.59141892 |
| 41 | Distal lower limb muscle weakness (HP:0009053) | 2.58517297 |
| 42 | Increased circulating renin level (HP:0000848) | 2.58306619 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.52416542 |
| 44 | Cervical subluxation (HP:0003308) | 2.52355775 |
| 45 | Ileus (HP:0002595) | 2.50298748 |
| 46 | Neonatal death (HP:0003811) | 2.49304533 |
| 47 | Vascular calcification (HP:0004934) | 2.47436871 |
| 48 | Abnormality of chloride homeostasis (HP:0011422) | 2.47176788 |
| 49 | Hydroxyprolinuria (HP:0003080) | 2.46176483 |
| 50 | Abnormality of proline metabolism (HP:0010907) | 2.46176483 |
| 51 | Atrophic scars (HP:0001075) | 2.45985175 |
| 52 | Nephritis (HP:0000123) | 2.44827656 |
| 53 | Abnormal ossification of hand bones (HP:0005921) | 2.42943826 |
| 54 | Potter facies (HP:0002009) | 2.42855740 |
| 55 | Facial shape deformation (HP:0011334) | 2.42855740 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.42242739 |
| 57 | Myoglobinuria (HP:0002913) | 2.38663418 |
| 58 | Natal tooth (HP:0000695) | 2.37285447 |
| 59 | Pili torti (HP:0003777) | 2.36149466 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.35737302 |
| 61 | Hypolipoproteinemia (HP:0010981) | 2.35605559 |
| 62 | Visceral angiomatosis (HP:0100761) | 2.35421653 |
| 63 | Thin bony cortex (HP:0002753) | 2.34940780 |
| 64 | Distal lower limb amyotrophy (HP:0008944) | 2.33937902 |
| 65 | Difficulty running (HP:0009046) | 2.33453601 |
| 66 | Hypoglycemic coma (HP:0001325) | 2.32628992 |
| 67 | Palmoplantar hyperkeratosis (HP:0000972) | 2.32554758 |
| 68 | Difficulty climbing stairs (HP:0003551) | 2.32426810 |
| 69 | Fragile nails (HP:0001808) | 2.32361964 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.31129544 |
| 71 | Broad metatarsal (HP:0001783) | 2.30271733 |
| 72 | Short nail (HP:0001799) | 2.28252371 |
| 73 | Hypoalbuminemia (HP:0003073) | 2.27491845 |
| 74 | Abnormal albumin level (HP:0012116) | 2.27491845 |
| 75 | Distal upper limb amyotrophy (HP:0007149) | 2.27154495 |
| 76 | Upper limb amyotrophy (HP:0009129) | 2.27154495 |
| 77 | Prolonged partial thromboplastin time (HP:0003645) | 2.24034994 |
| 78 | Popliteal pterygium (HP:0009756) | 2.23459641 |
| 79 | Abnormal hair laboratory examination (HP:0003328) | 2.23174106 |
| 80 | Trismus (HP:0000211) | 2.18291072 |
| 81 | Malnutrition (HP:0004395) | 2.14394266 |
| 82 | Hemangiomatosis (HP:0007461) | 2.14300686 |
| 83 | Ulnar bowing (HP:0003031) | 2.14278621 |
| 84 | Palpitations (HP:0001962) | 2.13824796 |
| 85 | Palmar hyperkeratosis (HP:0010765) | 2.13002170 |
| 86 | Stage 5 chronic kidney disease (HP:0003774) | 2.12132222 |
| 87 | Hypoplasia of dental enamel (HP:0006297) | 2.11001343 |
| 88 | Ankyloglossia (HP:0010296) | 2.10681377 |
| 89 | Syncope (HP:0001279) | 2.10658815 |
| 90 | Exercise-induced muscle cramps (HP:0003710) | 2.09568982 |
| 91 | Abdominal distention (HP:0003270) | 2.09535971 |
| 92 | Abnormal hand bone ossification (HP:0010660) | 2.08208672 |
| 93 | Cerebral aneurysm (HP:0004944) | 2.07862120 |
| 94 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.07267870 |
| 95 | Metaphyseal cupping (HP:0003021) | 2.04730812 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.04143800 |
| 97 | Abnormality of nucleobase metabolism (HP:0010932) | 2.02818420 |
| 98 | Proximal tubulopathy (HP:0000114) | 2.01642727 |
| 99 | Selective tooth agenesis (HP:0001592) | 2.00414335 |
| 100 | Joint hemorrhage (HP:0005261) | 1.99478812 |
| 101 | Aneurysm (HP:0002617) | 1.99367516 |
| 102 | Late onset (HP:0003584) | 1.99314241 |
| 103 | Rectal prolapse (HP:0002035) | 1.98669621 |
| 104 | Abnormality of nail color (HP:0100643) | 1.98374961 |
| 105 | Lipoatrophy (HP:0100578) | 1.98313170 |
| 106 | Abnormality of the Achilles tendon (HP:0005109) | 1.97593767 |
| 107 | Bronchomalacia (HP:0002780) | 1.95570537 |
| 108 | Abnormality of the nasal septum (HP:0000419) | 1.93985130 |
| 109 | Menorrhagia (HP:0000132) | 1.92749843 |
| 110 | Insulin resistance (HP:0000855) | 1.92528634 |
| 111 | Abnormality of complement system (HP:0005339) | 1.92324192 |
| 112 | Tubular atrophy (HP:0000092) | 1.90741134 |
| 113 | Plantar hyperkeratosis (HP:0007556) | 1.89778260 |
| 114 | Back pain (HP:0003418) | 1.89094665 |
| 115 | Widely patent fontanelles and sutures (HP:0004492) | 1.88980958 |
| 116 | Ventricular fibrillation (HP:0001663) | 1.87898453 |
| 117 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87045556 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 1.87045556 |
| 119 | Vertebral clefting (HP:0008428) | 1.86772750 |
| 120 | Hyperacusis (HP:0010780) | 1.86371200 |
| 121 | Woolly hair (HP:0002224) | 1.86210903 |
| 122 | Stridor (HP:0010307) | 1.85626914 |
| 123 | Chondrocalcinosis (HP:0000934) | 1.85162819 |
| 124 | Neonatal short-limb short stature (HP:0008921) | 1.85011846 |
| 125 | Acanthosis nigricans (HP:0000956) | 1.84823462 |
| 126 | Alkalosis (HP:0001948) | 1.84315587 |
| 127 | Ventricular arrhythmia (HP:0004308) | 1.83908103 |
| 128 | Wide cranial sutures (HP:0010537) | 1.83469367 |
| 129 | Hematochezia (HP:0002573) | 1.82720847 |
| 130 | Abnormality of renal excretion (HP:0011036) | 1.82653331 |
| 131 | Rhabdomyolysis (HP:0003201) | 1.82092550 |
| 132 | Neonatal onset (HP:0003623) | 1.81504061 |
| 133 | Ridged nail (HP:0001807) | 1.80817587 |
| 134 | Tubulointerstitial fibrosis (HP:0005576) | 1.80469537 |
| 135 | Atrial fibrillation (HP:0005110) | 1.80303483 |
| 136 | Fat malabsorption (HP:0002630) | 1.79964641 |
| 137 | Advanced eruption of teeth (HP:0006288) | 1.79895429 |
| 138 | Coxa vara (HP:0002812) | 1.79560697 |
| 139 | Hypoalphalipoproteinemia (HP:0003233) | 1.79517049 |
| 140 | Exercise-induced myalgia (HP:0003738) | 1.79106175 |
| 141 | Nail dystrophy (HP:0008404) | 1.77927537 |
| 142 | Hyperlipoproteinemia (HP:0010980) | 1.77880970 |
| 143 | Pigmentary retinal degeneration (HP:0001146) | 1.77490587 |
| 144 | Renal salt wasting (HP:0000127) | 1.77020798 |
| 145 | Dilated cardiomyopathy (HP:0001644) | 1.76303367 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.75783608 |
| 147 | Hyperglycinemia (HP:0002154) | 1.75651181 |
| 148 | Mitral stenosis (HP:0001718) | 1.74930378 |
| 149 | Abnormality of renin-angiotensin system (HP:0000847) | 1.73886572 |
| 150 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.72735543 |
| 151 | Abnormality of oral frenula (HP:0000190) | 1.72124408 |
| 152 | Shallow orbits (HP:0000586) | 1.72103882 |
| 153 | Abnormal urine output (HP:0012590) | 1.71975268 |
| 154 | Abnormal blistering of the skin (HP:0008066) | 1.69303391 |
| 155 | Achilles tendon contracture (HP:0001771) | 1.68933178 |
| 156 | Hyperkalemia (HP:0002153) | 1.67593694 |
| 157 | Subcapsular cataract (HP:0000523) | 1.67341055 |
| 158 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66678686 |
| 159 | Abnormal vertebral ossification (HP:0100569) | 1.64884390 |
| 160 | Conjugated hyperbilirubinemia (HP:0002908) | 1.64531698 |
| 161 | Spinal rigidity (HP:0003306) | 1.64310581 |
| 162 | Complement deficiency (HP:0004431) | 1.64067507 |
| 163 | Progressive sensorineural hearing impairment (HP:0000408) | 1.63730708 |
| 164 | Myocardial infarction (HP:0001658) | 1.63497663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.76270593 |
| 2 | EPHA2 | 3.94740104 |
| 3 | KDR | 3.85910774 |
| 4 | WNK4 | 3.20191946 |
| 5 | TTN | 2.88471761 |
| 6 | TRIB3 | 2.87459039 |
| 7 | EPHB2 | 2.66028622 |
| 8 | IRAK3 | 2.62277530 |
| 9 | ERN1 | 2.45240028 |
| 10 | PKN2 | 2.38223576 |
| 11 | BCKDK | 2.38210305 |
| 12 | TGFBR2 | 2.33236961 |
| 13 | RIPK1 | 2.29694941 |
| 14 | PTK6 | 2.15849140 |
| 15 | PAK4 | 2.09177578 |
| 16 | FER | 2.00194909 |
| 17 | TESK1 | 1.99571787 |
| 18 | MAP3K3 | 1.83647139 |
| 19 | SMG1 | 1.79980756 |
| 20 | PTK2 | 1.77790466 |
| 21 | LATS1 | 1.76064373 |
| 22 | EPHB1 | 1.75963404 |
| 23 | TGFBR1 | 1.73228943 |
| 24 | FGFR4 | 1.73149549 |
| 25 | MYLK | 1.64836822 |
| 26 | LMTK2 | 1.53596107 |
| 27 | OXSR1 | 1.43646115 |
| 28 | MAP2K3 | 1.38547469 |
| 29 | MST1R | 1.36171363 |
| 30 | STK39 | 1.32511902 |
| 31 | MET | 1.30430111 |
| 32 | STK38L | 1.28460062 |
| 33 | MAP2K2 | 1.28455990 |
| 34 | PDGFRA | 1.22047443 |
| 35 | SIK1 | 1.21614368 |
| 36 | CDK12 | 1.20860659 |
| 37 | INSRR | 1.18930243 |
| 38 | NME2 | 1.18804830 |
| 39 | LRRK2 | 1.18178206 |
| 40 | PDK4 | 1.11441087 |
| 41 | PDK3 | 1.11441087 |
| 42 | PDK2 | 1.09522847 |
| 43 | NEK1 | 1.08529700 |
| 44 | RPS6KB2 | 1.07200668 |
| 45 | DMPK | 1.06595269 |
| 46 | MAPKAPK3 | 1.04980682 |
| 47 | LATS2 | 1.04571838 |
| 48 | PRKG2 | 0.99967703 |
| 49 | MAP3K7 | 0.97490769 |
| 50 | MAP3K11 | 0.95678038 |
| 51 | TRPM7 | 0.93434243 |
| 52 | PTK2B | 0.93256374 |
| 53 | NTRK1 | 0.89864630 |
| 54 | STK10 | 0.89003152 |
| 55 | MAP3K10 | 0.87733271 |
| 56 | MAP2K1 | 0.85956885 |
| 57 | MAP3K2 | 0.81279574 |
| 58 | MTOR | 0.80836380 |
| 59 | PAK3 | 0.80322604 |
| 60 | NME1 | 0.78444324 |
| 61 | CDK8 | 0.78363874 |
| 62 | BMX | 0.76978186 |
| 63 | ARAF | 0.70679660 |
| 64 | FGFR3 | 0.70010699 |
| 65 | ERBB4 | 0.69678509 |
| 66 | CDC42BPA | 0.69157719 |
| 67 | CDK7 | 0.69144583 |
| 68 | FGFR1 | 0.69020534 |
| 69 | MAP3K9 | 0.66661870 |
| 70 | PRKD1 | 0.66532618 |
| 71 | GSK3A | 0.65614304 |
| 72 | MAP3K1 | 0.65062911 |
| 73 | ACVR1B | 0.63159029 |
| 74 | GRK1 | 0.62918253 |
| 75 | CAMK1D | 0.62856277 |
| 76 | PHKG2 | 0.62559696 |
| 77 | PHKG1 | 0.62559696 |
| 78 | RPS6KA2 | 0.61835057 |
| 79 | MST4 | 0.61381634 |
| 80 | ROCK1 | 0.59739752 |
| 81 | WNK3 | 0.57548982 |
| 82 | PIM2 | 0.56879351 |
| 83 | ABL2 | 0.51648952 |
| 84 | PBK | 0.51396554 |
| 85 | PAK2 | 0.51237081 |
| 86 | PRKAA2 | 0.50259289 |
| 87 | MAP3K12 | 0.49831247 |
| 88 | FGFR2 | 0.48851309 |
| 89 | MAP3K6 | 0.48252198 |
| 90 | STK38 | 0.46644920 |
| 91 | CSK | 0.45641679 |
| 92 | MAPK15 | 0.45570083 |
| 93 | ICK | 0.44246221 |
| 94 | MAP3K8 | 0.42014516 |
| 95 | AKT2 | 0.41795666 |
| 96 | KSR2 | 0.40989927 |
| 97 | NEK2 | 0.40113763 |
| 98 | STK24 | 0.38207999 |
| 99 | LIMK1 | 0.37450994 |
| 100 | ERBB2 | 0.37402199 |
| 101 | MELK | 0.37338333 |
| 102 | CAMK1G | 0.36699526 |
| 103 | MUSK | 0.36411845 |
| 104 | STK3 | 0.35925239 |
| 105 | PDGFRB | 0.35401299 |
| 106 | ILK | 0.35095796 |
| 107 | PRKCI | 0.33929028 |
| 108 | CDK6 | 0.33853088 |
| 109 | MAP2K6 | 0.33601288 |
| 110 | FLT3 | 0.33015697 |
| 111 | MAPK12 | 0.31678255 |
| 112 | SRC | 0.31631059 |
| 113 | PRKD3 | 0.31572241 |
| 114 | BRAF | 0.30403659 |
| 115 | BUB1 | 0.30144933 |
| 116 | PDPK1 | 0.29676974 |
| 117 | DYRK1B | 0.29628071 |
| 118 | EEF2K | 0.28969230 |
| 119 | DDR2 | 0.28636915 |
| 120 | PRKD2 | 0.27770961 |
| 121 | TAOK1 | 0.27323593 |
| 122 | PRKAA1 | 0.25514282 |
| 123 | JAK2 | 0.24720485 |
| 124 | RET | 0.24618107 |
| 125 | EGFR | 0.24225657 |
| 126 | MAPK11 | 0.24155807 |
| 127 | PRKCH | 0.23633016 |
| 128 | TYRO3 | 0.23218157 |
| 129 | CAMK2D | 0.23189633 |
| 130 | FRK | 0.22970429 |
| 131 | MAPKAPK2 | 0.22500280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08910553 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.79198257 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.75014173 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.60521126 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.49663999 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.40356547 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34807975 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.30143613 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29434130 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.17616716 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 2.12962435 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99136984 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96326045 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94265623 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.90039990 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.87438057 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87162731 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.72209325 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70712726 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.70432407 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61075997 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.57719946 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57284909 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.54250411 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.53701802 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.50073641 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46502910 |
| 28 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.45957939 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.45927626 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42061231 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38659726 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.38094515 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.37860275 |
| 34 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.37786497 |
| 35 | Adherens junction_Homo sapiens_hsa04520 | 1.34187927 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.32454644 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25654558 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22617830 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.22460554 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 1.22442065 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 1.21181290 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21089689 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18980307 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.16971785 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15511051 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13440183 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.11970561 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11345267 |
| 49 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.11201788 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10228146 |
| 51 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.09936224 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09764544 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 1.07480883 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.05968455 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05767669 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05293418 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05264382 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02126334 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01775239 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01379114 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01331974 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00078030 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99944467 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.99044150 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.89663156 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88233468 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85189523 |
| 68 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.83506504 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82827185 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81802832 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79273854 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74330590 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70855293 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70284527 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70102548 |
| 76 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68690068 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67664530 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66365635 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66353274 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66048279 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64834005 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64027907 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63264468 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.60382072 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59939944 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57663753 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56313371 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55099176 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54655914 |
| 90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53631967 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53327579 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53096603 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.52624260 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52221992 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52158559 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49389108 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47361184 |
| 98 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47358723 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47083538 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46226747 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45791062 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45657746 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45444688 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43669601 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43502573 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43478018 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42808450 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42707912 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.41576167 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41321593 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40988202 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40701224 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40622518 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39835458 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.39323834 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39276430 |
| 117 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37482108 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37285443 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36901488 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35159357 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34856746 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34005726 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33276551 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33101029 |
| 125 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32683495 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32513637 |

